| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Tetrault Lynn A. is a Director at NEO, with reported holdings spanning 3 companies. Recent filings cover 3 purchases and 14 sales. Those positions are worth an estimated $956K at current prices.
Our model assigns Tetrault Lynn A. a below-average insider score of 37/100, based on 6 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -57.8%.
Tetrault Lynn A.'s largest disclosed position is in NEO as Director, worth about $956K. The recent filings there lean toward selling, a net 14,726 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 21, 2015 | NEO Neogenomics Inc | Director | Buy | 9,500 | $8.21 | $77,995.00 | +187.7% | |
| Dec 7, 2015 | NEO Neogenomics Inc | Director | Buy | 3,500 | $7.72 | $27,020.00 | +224.4% |